Myelodysplastic Syndrome Drugs Market Report 2024-2033 with Analysis of Key Trends Including Erythropoiesis-Stimulating Agents Optimization, Combination Therapies Integration, Emphasis on Iron Chelation Therapy Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global myelodysplastic...

Myelodysplastic Syndrome Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - AbbVie, Gilead Sciences, Novartis, AstraZeneca, Sanofi, Incyte, Celgene, Fibrogen, Precigen New Year, USA, June 06, 2023 (GLOBE NEWSWIRE) -- Myelodysplastic Syndrome Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - AbbVie, Gilead Sciences, Novartis,...

DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape Las Vegas, USA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndrome as Influential Pharma Players Set Foot in the MDS Landscape ...